The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells

被引:94
作者
Jakubowicz-Gil, J
Paduch, R
Piersiak, T
Glowniak, K
Gawron, A
Kandefer-Szerszen, M
机构
[1] Marie Curie Sklodowska Univ, Dept Comparat Anat & Anthropol, PL-20033 Lublin, Poland
[2] Marie Curie Sklodowska Univ, Dept Virol & Immunol, PL-20033 Lublin, Poland
[3] Skubiszewski Med Univ, Med Plant Lab, Dept Pharmacognosy, PL-20093 Lublin, Poland
关键词
quercetin; cisplatin; apoptosis; Hsp72; MRP; HeLa cells;
D O I
10.1016/j.bcp.2005.01.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is well known that some tumour cells are very resistant to chemotherapy-induced cell death which indicate poor prognosis for patients. Thus the aim of the present study was to investigate the effect of quercetin on pro-apoptotic activity of cisplatin in human cervix carcinoma cells (HeLa). Three variants of experiments were performed. In the first one cells were incubated with studied drugs separately for 8 and 24 h. In the second, drugs were added to the culture medium simultaneously. In third cisplatin or quercetin addition was followed by subsequent quercetin or cisplatin treatment, respectively. We observed different apoptotic effects, dependent on the drug succession. Preincubation of cells with quercetin followed by cisplatin treatment appeared to be the most effective and was correlated with strong activation of caspase-3 and inhibition of both heat shock proteins (Hsp72) and multi-drug resistance proteins (MRP) levels. Our results indicate that quercetin pretreatment sensitizes HeLa cells to cisplatin-induced apoptosis in HeLa cells. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1343 / 1350
页数:8
相关论文
共 71 条
[1]  
Akiyama S, 1999, ANTI-CANCER DRUG DES, V14, P143
[2]  
Balabhadrapathruni S, 2000, ONCOL REP, V7, P3
[3]  
Beissinger M, 1998, BIOL CHEM, V379, P245
[4]   Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].
Birt, DF ;
Hendrich, S ;
Wang, WQ .
PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177
[5]   Recent advances in the imaging of programmed cell death [J].
Blankenberg, FG .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (13) :1457-1467
[6]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[7]   Differential modulation of cisplatin and doxorubicin efficacies in leukemia cells by flavonoids [J].
Cipák, L ;
Novotny, L ;
Cipáková, I ;
Rauko, P .
NUTRITION RESEARCH, 2003, 23 (08) :1045-1057
[8]  
Cipák L, 2003, LEUKEMIA RES, V27, P65, DOI 10.1016/S0145-2126(02)00063-2
[9]   Therapeutic applications of heat shock proteins and molecular chaperones [J].
Clark, JI .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (07) :1153-1160
[10]   Flavonoids - Chemistry, metabolism, cardioprotective effects, and dietary sources [J].
Cook, NC ;
Samman, S .
JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 1996, 7 (02) :66-76